Skip to content
CompanySight
Company No. 09910964 · Incorporated 10 Dec 2015

Cenote Pharma Limited

Registered name: CENOTE PHARMA LIMITED

Part of Aphl 2 Limited group

Cenote Pharma Limited does not publish its revenue or profit.

Cenote Pharma Limited did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 31 Dec 2025 showed 0 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Godalming; we hold 5 years of its filed accounts.

Balance sheet onlySection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods
Status
Active
Location
Godalming, South East
Age
10 yrs · since 2015
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The company is wholly owned by”

Latest accounts · year to 31 Dec 2025

Key figures

Small team

Revenue not disclosed

Cenote Pharma Limited’s accounts for the year to 31 Dec 2025 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.

We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.

Employees
0
Net assets
—

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

5 filed years

Financial history

Multi-year financials, oldest to newest
Year to30 Oct 202230 Oct 20236 Mar 202431 Dec 202431 Dec 2025
DisclosureNo P&LNo P&LNo P&LNo P&LNo P&L
Profit & loss
Revenue (turnover)—————
Profit (best available)—————
Employees (average)33300
Ratios
Profit margin—————
Growth (year on year)
Headcount growth—0%—▼100%—
Balance sheet — indirect signals, not revenue
Cash at bank£367k£31.4k£63.3k£0—
Net assets£322k£225k£219k£4.5k—
Fixed assets£4.9k£101k£2.5k——
Current assets£824k£884k£758k£4.5k—
Debtors£372k£371k£286k£0£4.5k
SourceFullAccounts · bulk data Jun 2024FullAccounts · bulk data Jun 2024FullAccounts · bulk data Aug 2024FullAccounts · bulk data Jul 2025FullAccounts · bulk data Aug 2026
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now —
Cash at bank
—
Now —
Headcount
—
Now 0
Deferred income
—
Now —
Fixed assets
—
Now —
Corporate ownership

Group structure

Ownership chain

  1. Aphl 2 Limitedultimate parent75–100%
  2. Aspire Pharma Limited75–100%
  3. Cenote Pharma Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (3)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Dec 2025, from the Companies House accounts bulk data published Aug 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.